Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain
暂无分享,去创建一个
Vitor Mendes Pereira | Stylianos E. Antonarakis | Taufik Valiante | Timo Krings | Ivan Radovanovic | Gelareh Zadeh | Joshua D. Wythe | Alexander M. Herman | Behnam Rezai Jahromi | T. Kiehl | S. Antonarakis | S. Nikolaev | J. Fish | V. Pereira | T. Krings | T. Valiante | G. Zadeh | S. Ylä-Herttuala | M. Tymianski | X. Bonilla | I. Radovanovic | T. Rauramaa | Juhana Frösen | J. Frösen | B. Jahromi | Hugo Andrade-Barazarte | S. Jauhiainen | Ximena Bonilla | Tuomas Rauramaa | Seppo Ylä‐Herttuala | Sergey I. Nikolaev | Sandra Vetiska | Emilie Boudreau | Suvi Jauhiainen | Nadiya Khyzha | Peter V. DiStefano | Santeri Suutarinen | Tim‐Rasmus Kiehl | Hugo Andrade‐Barazarte | Takyee Tung | Mike Tymianski | Jason E. Fish | Nadiya Khyzha | Émilie Boudreau | S. Suutarinen | S. Vetiska | Takyee Tung | B. R. Jahromi | Santeri Suutarinen
[1] Yajie Wang,et al. Receptors of the Notch signaling pathway are associated with hemorrhage of brain arteriovenous malformations. , 2014, Molecular medicine reports.
[2] A. Cuadrado,et al. Mechanisms and functions of p38 MAPK signalling. , 2010, The Biochemical journal.
[3] Tyson N. Kim,et al. Notch4 Normalization Reduces Blood Vessel Size in Arteriovenous Malformations , 2012, Science Translational Medicine.
[4] L. Wood,et al. Cancer‐Associated Mutations in Endometriosis without Cancer , 2017, The New England journal of medicine.
[5] I. Awad,et al. Expression of Endothelial Cell Angiogenesis Receptors in Human Cerebrovascular Malformations , 2001, Neurosurgery.
[6] G. Pavesi,et al. Endothelial cells from human cerebral aneurysm and arteriovenous malformation release ET-1 in response to vessel rupture. , 2006, International journal of molecular medicine.
[7] S. Cagnol,et al. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition , 2013, Oncogene.
[8] W. Chung,et al. Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling , 2017, Circulation.
[9] D. Bar-Sagi,et al. A Lipid-Anchored Grb2-Binding Protein That Links FGF-Receptor Activation to the Ras/MAPK Signaling Pathway , 1997, Cell.
[10] J. Mulliken,et al. Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation. , 2017, American journal of human genetics.
[11] J. Mulliken,et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast‐flow vascular anomalies are caused by RASA1 mutations , 2008, Human mutation.
[12] M. Lawton,et al. Notch-1 signalling is activated in brain arteriovenous malformations in humans. , 2009, Brain : a journal of neurology.
[13] A. Bollen,et al. Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease , 2009, Laboratory Investigation.
[14] Tyson N. Kim,et al. Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice , 2008, Proceedings of the National Academy of Sciences.
[15] A. Rustgi,et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4) , 2004, The Lancet.
[16] Peter J Park,et al. A dynamic H3K27ac signature identifies VEGFA-stimulated endothelial enhancers and requires EP300 activity , 2013, Genome research.
[17] J. Mulliken,et al. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma. , 2016, American journal of human genetics.
[18] S. Lewis. Prevalence of adults with brain arteriovenous malformations , 2002 .
[19] Joshua D. Wythe,et al. The molecular regulation of arteriovenous specification and maintenance , 2015, Developmental dynamics : an official publication of the American Association of Anatomists.
[20] M. Hellström,et al. Notch as a hub for signaling in angiogenesis. , 2013, Experimental cell research.
[21] C. Warlow,et al. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. , 2001, Brain : a journal of neurology.
[22] K. Pumiglia,et al. Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation* , 2001, The Journal of Biological Chemistry.
[23] D. W. Johnson,et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.
[24] D. W. Johnson,et al. Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.
[25] Frank McCormick,et al. RAS Proteins and Their Regulators in Human Disease , 2017, Cell.
[26] N. Kamitaki,et al. Endothelial Cells from Capillary Malformations Are Enriched for Somatic GNAQ Mutations , 2016, Plastic and reconstructive surgery.
[27] Alexander Dobrovic,et al. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase , 2012, Oncotarget.
[28] D. Wiebers,et al. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992 , 1996, Neurology.
[29] J. Mulliken,et al. A somatic MAP3K3 mutation is associated with verrucous venous malformation. , 2015, American journal of human genetics.
[30] A. Adjei,et al. The clinical development of MEK inhibitors , 2014, Nature Reviews Clinical Oncology.
[31] Tyson N. Kim,et al. Constitutively active Notch4 receptor elicits brain arteriovenous malformations through enlargement of capillary-like vessels , 2014, Proceedings of the National Academy of Sciences.
[32] R. Helaers,et al. Somatic Activating PIK3CA Mutations Cause Venous Malformation. , 2015, American journal of human genetics.
[33] H. Dressman,et al. Gene Microarray Analysis of Human Brain Arteriovenous Malformations , 2004, Neurosurgery.
[34] Michael J. Parsons,et al. Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey , 2014, Oncogene.
[35] L. Ferrarini,et al. EndMT contributes to the onset and progression of cerebral cavernous malformations , 2013, Nature.